ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 18 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,025,762 | 0.19% |
| Perceptive Advisors | 781,615 | $3,657,958 | 0.11% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 24,000 | $112,320 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 177,610 | $840,095 | 0.03% |
| DIMENSIONAL FUND ADVISORS LP | 24,004 | $113,538 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,060 | $9,641 | 0.00% |
| NORTHERN TRUST CORP | 17,074 | $79,906 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 83,083 | $392,982 | 0.00% |
| STATE STREET CORP | 21,500 | $101,695 | 0.00% |